SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001558370-20-006307
Filing Date
2020-05-11
Accepted
2020-05-11 17:12:53
Documents
5
Effectiveness Date
2020-05-11

Document Format Files

Seq Description Document Type Size
1 S-8 axsm-20200508xs8.htm S-8 89390
2 EX-5.1 axsm-20200508xex5d1.htm EX-5.1 10867
3 EX-23.2 axsm-20200508xex23d2.htm EX-23.2 7934
4 EX-99.3 axsm-20200508xex99d3.htm EX-99.3 79351
5 EX-99.4 axsm-20200508xex99d4.htm EX-99.4 79679
  Complete submission text file 0001558370-20-006307.txt   268197
Mailing Address 200 BROADWAY, 3RD FLOOR NEW YORK NY 10038
Business Address 200 BROADWAY, 3RD FLOOR NEW YORK NY 10038 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-238174 | Film No.: 20865996
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences